Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia
- PMID: 2602422
Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia
Abstract
Regional neuronal loss in the substantia nigra (SN) was studied in relation to extrapyramidal symptoms and dementia in 27 patients with Alzheimer's disease (AD), 12 patients with idiopathic Parkinson's disease (PD) and 18 controls. Four areas of the right SN were investigated at the level of the caudal red nucleus. In AD the number of neurons were reduced to 97%, 79%, 83% and 78% of the control values from the medial to lateral SN respectively. The number of lateral neurons showed a negative correlation with the severity of rigidity and hypokinesia. The degree of dementia did not have a significant correlation with nigral neuronal counts. In PD, the number of neurons was markedly reduced in all parts of the SN, most pronouncedly in the lateral part. The number of lateral neurons showed a negative correlation with the severity of rigidity and hypokinesia, whereas tremor had a positive correlation. The degree of dementia of the patients had a negative correlation with the number of medial neurons, suggesting that degeneration of the nigrostriatal neurons may contribute as a subcortical component to dementia in PD patients.
Similar articles
-
Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra.Ann Neurol. 1989 Jul;26(1):47-50. doi: 10.1002/ana.410260107. Ann Neurol. 1989. PMID: 2549846
-
Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison with those in Parkinson's and Alzheimer's diseases.Ann Neurol. 1990 May;27(5):520-7. doi: 10.1002/ana.410270511. Ann Neurol. 1990. PMID: 1694418
-
Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.Acta Neuropathol. 2003 Sep;106(3):191-201. doi: 10.1007/s00401-003-0725-y. Epub 2003 Jul 5. Acta Neuropathol. 2003. PMID: 12845452
-
Neuropathological substrates of Alzheimer's disease and Parkinson's disease.J Neural Transm Suppl. 1987;24:109-29. J Neural Transm Suppl. 1987. PMID: 3316494 Review.
-
[The neuropathology of Parkinson syndrome].Rev Neurol (Paris). 1988;144(4):229-48. Rev Neurol (Paris). 1988. PMID: 2843979 Review. French.
Cited by
-
A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer's Disease.Front Aging Neurosci. 2016 Jul 12;8:171. doi: 10.3389/fnagi.2016.00171. eCollection 2016. Front Aging Neurosci. 2016. PMID: 27462267 Free PMC article.
-
The genetic association between apolipoprotein E gene polymorphism and Parkinson disease: A meta-Analysis of 47 studies.Medicine (Baltimore). 2018 Oct;97(43):e12884. doi: 10.1097/MD.0000000000012884. Medicine (Baltimore). 2018. PMID: 30412083 Free PMC article.
-
Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains.Ann Clin Transl Neurol. 2019 Aug;6(8):1423-1434. doi: 10.1002/acn3.50837. Epub 2019 Jul 9. Ann Clin Transl Neurol. 2019. PMID: 31402620 Free PMC article.
-
Truncated tau deregulates synaptic markers in rat model for human tauopathy.Front Cell Neurosci. 2015 Feb 23;9:24. doi: 10.3389/fncel.2015.00024. eCollection 2015. Front Cell Neurosci. 2015. PMID: 25755633 Free PMC article.
-
Nutraceutical and Probiotic Approaches to Examine Molecular Interactions of the Amyloid Precursor Protein APP in Drosophila Models of Alzheimer's Disease.Int J Mol Sci. 2021 Jun 29;22(13):7022. doi: 10.3390/ijms22137022. Int J Mol Sci. 2021. PMID: 34209883 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical